📰 Zai Lab News
Page 61 - Zai Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zai Lab. Real-time updates on events, politics, business and more.
March 26, 2022
Zai Lab Limited (NASDAQ:ZLAB – Get Rating)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $43.82, but opened at $45.54. Zai Lab shares last traded at $44.54, with a volume of 14,620 shares traded. A number of equities research analysts have recently weighed in on ZLAB […]
March 26, 2022
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...
March 25, 2022
The situation between U.S. and Chinese regulators over Chinese stocks listed on U.S. exchanges continues to evolve.
March 24, 2022
The SEC has singled out Yum China, four others for potential delisting in 2024 over accounting standards.
March 23, 2022
Fort Lauderdale, FL — March 22, 2022 — Nova Southeastern University (NSU) has been awarded $1.94 million in National Defense Authorization Act [...]
March 22, 2022
/PRNewswire/ -- Qiming Venture Partners portfolio company Arrail Group (SEHK: 06639), a leading dental services provider in China, today listed on the main...
March 22, 2022
First-line maintenance with niraparib at an individualized starting dose improved progression-free survival in advanced ovarian cancer.
March 21, 2022
PRIME study demonstrates that niraparib treatment had a statistically significant and clinically meaningful improvement in progression-free survival in the...
March 21, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
March 21, 2022
21.03.2022 - PRIME study demonstrates that niraparib treatment had a statistically significant and clinically meaningful improvement in progression-free survival in the overall study population regardless of biomarker status when compared to placeboThe primary ... Seite 1